Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-05-06

Clinical Trial Update: Ginkgolide With Intravenous Alteplase Thrombolysis in Acute Ischemic Stroke Neurological Improving Trial [Phase 4]

View source ↗

Summary

Phase 4 trial updating the use of ginkgolide with intravenous alteplase thrombolysis for acute ischemic stroke has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alteplase (alteplase)
  • Ginkgolide (ginkgolide)

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Intravenous Alteplase Thrombolysis, Neurological Improving | Phase 4 | Status: COMPLETED